Biotech-Insider (@BiotechOptions2) header
Biotech-Insider (@BiotechOptions2) profile picture
Joined July 2015
Biotech-Insider retweeted
#Biotech companies expected to price #IPO next week: $RUBY Rubius Tx. 9.53M shares at $20-$22/share $ALLK Allakos 6M shares at $15-$17 $CNST Constellation 5.34M shares $14-$16 $REPL Replimune 6.7M shares at $14-$16 $CRNX Crinetics 5M shares at $15-$17
Biotech-Insider retweeted
Biotech-Insider retweeted
New approach to #immunotherapy leads to complete response in breast cancer patient medicalxpress.com/news/2018-… #BCSM #ASCO18 Finally had time to check out Steven Rosenberg's new TIL paper. Really amazing scans! nature.com/articles/s41591-0…
9
37
6
114
Biotech-Insider retweeted
In biotech, $6 billion can vanish quickly wsj.com/articles/in-biotech-…
1
5
13
Biotech-Insider retweeted
Replying to @_B_I_O_T_E_C_H_
$CRSP $129 target...ROFL...$6B market cap target to $SGMO: $6.7B.
1
2
Biotech-Insider retweeted
4 Powerful SEO Tips to Fast-track Your Biotech Business To The Top #biotechSEO #lifeScienceSEO #biotechWeb https://teapawt.net/t.co/EuONXfcBY6
1
1
Biotech-Insider retweeted
House passes Trump-backed drug bill, letting sick patients bypass FDA politico.com/story/2018/05/2…
20
22
4
35
FDA plans to speed path to approval for some gene therapies, starting with hemophilia statnews.com/2018/05/22/fda-… via @ikeswetlitz $BMRN $ONCE $QURE $PFE
4
12
4
34
Biotech-Insider retweeted
The FDA has approved a preventive treatment option for migraine patients cnn.it/2Lcq2Na
29
155
50
386
Biotech-Insider retweeted
The Biotech Forum: $DVAX $IMDZ $TGTX 3 Small Oncology Stocks That Could Get An "ASCO" Boost Next Week… dlvr.it/PGZkl3 #MedicBoard
15
13
Biotech-Insider retweeted
#Biotech Data Likely in May $AVEO TIVO-3* $BMRN HemoA $CARA Pain $CLSD DME $EBIO VISTA $ESPR Ph3 $EXEL IMblaze370* $GBT HOPE Part A $GEMP Ph2 $MDGL Biopsy data $NBRV Ph3 $JNJ Esketamine Ph3 $URGN Ph3 5/16 #ASCO18 abstracts 5/17 #EHA18 abstracts #ASGCT18 $ABEO $BOLD $RCKT $SRPT
7
49
2
119
Biotech-Insider retweeted
Forget Amazon, Apple, and Intel. These biotech companies are the next Silicon Valley darlings trib.al/jCA9KZI
4
134
10
300
FDA approval decision on Keytruda combination expected by late September dlvr.it/QRG59X MARKETWATCH
Biotech-Insider retweeted
The @US_FDA has accepted for priority review the Biologics License Application for cemiplimab for patients with metastatic cutaneous squamous cell carcinoma. The target action date for the FDA decision on the @Regeneron / @sanofi drug is October 28, 2018. raredr.com/link/3395
Biotech-Insider retweeted
#Biotech $XBI $IBB $NBI Fire Sale: 2Top Stocks to Buy Next Week Get in on the ground floor $SGMO risk-to-reward ratio is arguably heavily skewed toward the upside as things stand now incredible buying opportunity for investors with a long-term mindset fool.com/investing/2018/04/0…
Biotech-Insider retweeted
Jefferies: 4 biotech stocks to buy that could be acquired within the next 18 months $AVXS $TGTX $NBIX $RIGL 247wallst.com/healthcare-bus…
1
15
1
22
Biotech-Insider retweeted
It's time to trade some biotechs.  buff.ly/2DMJF9G
7
6